Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
Public ClinicalTrials.gov record NCT02013544. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02013544
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- EndoCeutics Inc.
- Industry
- Enrollment
- 558 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Prasterone (DHEA) Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2014
- Primary completion
- Dec 31, 2014
- Completion
- Jan 31, 2015
- Last update posted
- May 31, 2017
2014 – 2015
United States locations
- U.S. sites
- 24
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| EndoCeutics site # 39 | Montgomery | Alabama | 36117 | — |
| EndoCeutics site # 14 | Tucson | Arizona | 85712 | — |
| EndoCeutics site # 21 | Sacramento | California | 95821 | — |
| EndoCeutics site # 83 | San Diego | California | 92103 | — |
| EndoCeutics site # 30 | San Diego | California | 92108 | — |
| EndoCeutics site # 36 | Denver | Colorado | 80209 | — |
| EndoCeutics site # 52 | Denver | Colorado | 80220 | — |
| EndoCeutics site # 45 | Boynton Beach | Florida | 33472 | — |
| EndoCeutics site # 60 | Lake Worth | Florida | 33461 | — |
| EndoCeutics site # 54 | North Miami | Florida | 33161 | — |
| EndoCeutics site # 80 | West Palm Beach | Florida | 33409 | — |
| EndoCeutics site # 23 | Atlanta | Georgia | 30328 | — |
| EndoCeutics site # 55 | Wichita | Kansas | 67226 | — |
| EndoCeutics site # 86 | Louisville | Kentucky | 40291 | — |
| EndoCeutics site # 27 | Lutherville | Maryland | 21093 | — |
| EndoCeutics site # 87 | Lawrenceville | New Jersey | 08648 | — |
| EndoCeutics site # 81 | Plainsboro | New Jersey | 08536 | — |
| EndoCeutics site # 05 | Cleveland | Ohio | 44122 | — |
| EndoCeutics site # 15 | Columbus | Ohio | 43213 | — |
| EndoCeutics site # 75 | Philadelphia | Pennsylvania | 19114-1029 | — |
| EndoCeutics site # 84 | Corpus Christi | Texas | 78414 | — |
| EndoCeutics site # 82 | Houston | Texas | 77030 | — |
| EndoCeutics site # 03 | Norfolk | Virginia | 23507 | — |
| EndoCeutics site # 76 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02013544, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02013544 live on ClinicalTrials.gov.